Valneva: to present research on chikungunya
(CercleFinance.com) - Vaccine company Valneva yesterday announced that it will make presentations on chikungunya at various leading scientific conferences in Q4 2023.
At IDWeek, the annual meeting of the Infectious Diseases Society of America (IDSA), to be held in Boston, Valneva will host the panel entitled "Chikungunya is an Increasing Global Threat: The Need for Better Protection".
At the 2023 annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Chicago, Valneva will also make two presentations on chikungunya and present three posters on the subject.
Valneva will also attend World Vaccine Congress Europe (Barcelona, 16 to 19 October), and at the annual congress of the International Society of Vaccines in Lausanne, before the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), from 12 to 15 November in Copenhagen.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
At IDWeek, the annual meeting of the Infectious Diseases Society of America (IDSA), to be held in Boston, Valneva will host the panel entitled "Chikungunya is an Increasing Global Threat: The Need for Better Protection".
At the 2023 annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Chicago, Valneva will also make two presentations on chikungunya and present three posters on the subject.
Valneva will also attend World Vaccine Congress Europe (Barcelona, 16 to 19 October), and at the annual congress of the International Society of Vaccines in Lausanne, before the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), from 12 to 15 November in Copenhagen.
Copyright (c) 2023 CercleFinance.com. All rights reserved.